UPDATE : Wednesday, December 11, 2019
상단여백
US sales of Remicade drop due to biosimilar’s rise by Jeong Sae-im 2019-10-17 13:32
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar by Jeong Sae-im 2019-10-16 14:16
Kolon Life Science shares surge after TissueGene’s survival by Jeong Sae-im 2019-10-14 18:01
HLB merges with Elevar to own rivoceranib rights by Jeong Sae-im 2019-10-14 14:43
‘Kosdaq firms listed for exceptional tech need special monitoring’ by Jeong Sae-im 2019-10-07 15:51
라인
Samsung execs pass buck to biotech subsidiaries for destroying evidence by Jeong Sae-im 2019-10-04 11:42
Regulator raids cell therapy makers too often to little avail by Jeong Sae-im 2019-10-02 11:23
Will parliamentary audit uncover why Invossa was mislabeled? by Jeong Sae-im 2019-10-01 15:45
Ranitidine recall taking heavy toll on pharmaceuticals by Jeong Sae-im 2019-09-30 15:16
Regulator explained why it banned stomach medicine ranitidine altogether by Jeong Sae-im 2019-09-27 15:02
라인
‘Samsung BioLogics destroyed evidence to hide accounting fraud for months’ by Jeong Sae-im 2019-09-26 15:24
Helixmith blames hospital for absurd drug mix-up by Jeong Sae-im 2019-09-25 13:42
Court rejects Kolon’s appeal over Invossa license revocation by Jeong Sae-im 2019-09-25 11:18
FDA recommends Kolon to remanufacture Invossa’s second fluid by Jeong Sae-im 2019-09-23 15:32
Drug firms uncertain about pricing of quadrivalent flu vaccines by Jeong Sae-im 2019-09-23 14:52
라인
‘Galderma Korea ran background checks on unionized workers’ by Jeong Sae-im 2019-09-19 15:18
Regulator delays decision on delisting Kolon TissueGene by Jeong Sae-im 2019-09-18 14:27
Biotech startups seek IPO via ‘growth potential exception’ policy by Jeong Sae-im 2019-09-17 11:26
Chong Kun Dang wins patent suit against Novartis over immunosuppressant by Jeong Sae-im 2019-09-11 15:16
Daewoong to test botulinum toxin Nabota for hair loss by Jeong Sae-im 2019-09-11 13:56
여백
여백
여백
Back to Top